A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancerSarah E. Paraghamian, Victoria Bae‐Jump, Gabrielle M. Hawkins et al.|Cancer Biology & Therapy|2023Cited by 11